United States — Centers for Disease Control and Prevention & Gilead Sciences
10 shared events · Importance 3 · Last updated Jul 31, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Accidents
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention is assisting in the safe withdrawal of affected Americans, deploying experts to Africa, and monitoring the outbreak while emphasizing the low risk to the United States.
Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Accidents
United States — Centers for Disease Control and Prevention: Coordinating regional response and urging intensified efforts to slow the outbreak.
Gilead Sciences: Developed obeldesivir, the antiviral being tested in the EBO-PEP trial.
Jul 06, 2026 · 410 articles
Tech
United States — Centers for Disease Control and Prevention: United States — Centers for Disease Control and Prevention is partnering with the World Health Organization and authorities in the Democratic Republic of the Congo and Uganda to design and implement clinical trials.
Gilead Sciences: Gilead Sciences developed the antiviral remdesivir and experimental oral antiviral obeldesivir, both prioritized by the World Health Organization for treatment and prevention of the Bundibugyo strain of Ebola.
May 28, 2026 · 6 articles
Accidents
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention>>> declared the Ebola outbreak a Public Health Emergency of Continental Security, emphasizing the urgency of coordinated action and mobilizing resources for response and preparedness.
Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.
May 18, 2026 · 505 articles
Tech
United States — Centers for Disease Control and Prevention: Guidelines referenced in the study; findings may reinforce its recommendations for antiviral use.
Gilead Sciences: Manufactures remdesivir (Veklury). Positive study results may support increased use and sales in transplant populations.
Jul 28, 2026 · 6 articles
Accidents
United States — Centers for Disease Control and Prevention: Confirmed a U.S. citizen infected; providing technical assistance.
Gilead Sciences: Supplying remdesivir for clinical trials; potential positive impact if treatment proves effective.
Mar 09, 2018 · 314 articles
International
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention believes the Ebola outbreak is larger than currently detected and emphasizes the need for community trust in the response.
Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.
May 21, 2026 · 627 articles
International
United States — Centers for Disease Control and Prevention: United States — Centers for Disease Control and Prevention>>> has stated the risk of Ebola to the general public in the United States>>> remains low and is working with the United States — United States Department of State>>> to identify tertiary facilities in Europe.
Gilead Sciences: Gilead Sciences' antiviral remdesivir is mentioned as a potential treatment to be used at the quarantine facility, indicating its role in the medical response to Ebola.
May 26, 2026 · 213 articles
Business
United States — Centers for Disease Control and Prevention: CDC is mentioned as an agency where Brosgart served as a Senior Advisor; no direct impact.
Gilead Sciences: Gilead Sciences is mentioned as Brosgart's former employer, where she contributed to antiviral drug development; no direct impact on Gilead.
Aug 17, 2026 · 6 articles
Domestic
United States — Centers for Disease Control and Prevention: Provided guidelines referenced in diary.
Gilead Sciences: Gilead is mentioned in relation to Remdesivir, but it is not directly involved in the event. Its role is peripheral.
Jul 26, 2026 · 353 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Centers for Disease Control and Prevention and Gilead Sciences interact across events, view sentiment trends, and discover connected entities.
Open Dashboard